Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gleave

Showing results (191-200 of 940) with videos related to

Pageof 94
Sort By:
International Journal of Cancer|March 29, 2001
Synergistic chemosensitization and inhibition of progression to androgen independence by antisense Bcl-2 oligodeoxynucleotide and paclitaxel in the LNCaP prostate tumor modelS Leung, H Miyake, T Zellweger, et al.
Molecular Cancer Therapeutics|February 17, 2005
Synergistic antitumor effect of combined use of adenoviral-mediated p53 gene transfer and antisense oligodeoxynucleotide targeting clusterin gene in an androgen-independent human prostate cancer modelKazuki Yamanaka, Martin E Gleave, Isao Hara, et al.
The Journal of Urology|April 17, 2002
Introducing the clusterin gene into human renal cell carcinoma cells enhances their metastatic potentialHideaki Miyake, Martin E Gleave, Soichi Arakawa, et al.
Nature Reviews. Urology|December 17, 2014
Targeting heat shock proteins in metastatic castration-resistant prostate cancerArun A Azad, Amina Zoubeidi, Martin E Gleave, et al.
American Journal of Physiology. Renal Physiology|January 31, 2014
Promotion of cell proliferation by clusterin in the renal tissue repair phase after ischemia-reperfusion injuryChristopher Y C Nguan, Qiunong Guan, Martin E Gleave, et al.
Clinical Symposia (Summit, N.J. : 1957)|January 1, 1977
Congenital and traumatic intracranial aneurysmsA L Rhoton, F E Jackson, J Gleave, et al.
Neurosurgery|January 1, 1984
Delayed traumatic intracerebral hematoma: report of 15 cases operatively treatedH A Young, J R Gleave, H H Schmidek, et al.
British Journal of Cancer|June 22, 1999
Clinico-pathological and treatment-related factors influencing survival in parotid cancerA G Renehan, E N Gleave, N J Slevin, et al.
Urology|December 22, 1999
Targeting bcl-2 gene to delay androgen-independent progression and enhance chemosensitivity in prostate cancer using antisense bcl-2 oligodeoxynucleotidesM E Gleave, H Miayake, J Goldie, et al.
Methods in Molecular Medicine|May 3, 2003
Application of gene microarrays in the study of prostate cancerColleen C Nelson, Douglas Hoffart, Martin E Gleave, et al.
Pageof 94

Showing results (191-200 of 940) with videos related to

Sort By:
Pageof 94
International Journal of Cancer|March 29, 2001
Synergistic chemosensitization and inhibition of progression to androgen independence by antisense Bcl-2 oligodeoxynucleotide and paclitaxel in the LNCaP prostate tumor modelS Leung, H Miyake, T Zellweger, et al.
Molecular Cancer Therapeutics|February 17, 2005
Synergistic antitumor effect of combined use of adenoviral-mediated p53 gene transfer and antisense oligodeoxynucleotide targeting clusterin gene in an androgen-independent human prostate cancer modelKazuki Yamanaka, Martin E Gleave, Isao Hara, et al.
The Journal of Urology|April 17, 2002
Introducing the clusterin gene into human renal cell carcinoma cells enhances their metastatic potentialHideaki Miyake, Martin E Gleave, Soichi Arakawa, et al.
Nature Reviews. Urology|December 17, 2014
Targeting heat shock proteins in metastatic castration-resistant prostate cancerArun A Azad, Amina Zoubeidi, Martin E Gleave, et al.
American Journal of Physiology. Renal Physiology|January 31, 2014
Promotion of cell proliferation by clusterin in the renal tissue repair phase after ischemia-reperfusion injuryChristopher Y C Nguan, Qiunong Guan, Martin E Gleave, et al.
Clinical Symposia (Summit, N.J. : 1957)|January 1, 1977
Congenital and traumatic intracranial aneurysmsA L Rhoton, F E Jackson, J Gleave, et al.
Neurosurgery|January 1, 1984
Delayed traumatic intracerebral hematoma: report of 15 cases operatively treatedH A Young, J R Gleave, H H Schmidek, et al.
British Journal of Cancer|June 22, 1999
Clinico-pathological and treatment-related factors influencing survival in parotid cancerA G Renehan, E N Gleave, N J Slevin, et al.
Urology|December 22, 1999
Targeting bcl-2 gene to delay androgen-independent progression and enhance chemosensitivity in prostate cancer using antisense bcl-2 oligodeoxynucleotidesM E Gleave, H Miayake, J Goldie, et al.
Methods in Molecular Medicine|May 3, 2003
Application of gene microarrays in the study of prostate cancerColleen C Nelson, Douglas Hoffart, Martin E Gleave, et al.
Pageof 94